William Blair Predicts Beauty Health FY2024 Earnings

The Beauty Health Company (NASDAQ:SKIN - Free Report) - Equities research analysts at William Blair issued their FY2024 earnings per share estimates for Beauty Health in a report issued on Wednesday, November 13th. William Blair analyst M. Andrew expects that the company will post earnings per share of ($0.29) for the year. The consensus estimate for Beauty Health's current full-year earnings is ($0.25) per share. William Blair also issued estimates for Beauty Health's FY2025 earnings at ($0.43) EPS.

A number of other brokerages have also weighed in on SKIN. Stifel Nicolaus dropped their price target on Beauty Health from $4.00 to $2.00 and set a "hold" rating on the stock in a research note on Friday, July 26th. Piper Sandler reaffirmed an "underweight" rating and set a $1.00 target price (down previously from $1.50) on shares of Beauty Health in a report on Friday, August 9th. Finally, Canaccord Genuity Group lifted their target price on Beauty Health from $1.25 to $1.75 and gave the stock a "hold" rating in a report on Wednesday, November 13th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $2.55.

Beauty Health Stock Up 3.9 %

SKIN traded up $0.06 on Monday, hitting $1.59. The company had a trading volume of 605,743 shares, compared to its average volume of 1,862,148. Beauty Health has a 12-month low of $0.91 and a 12-month high of $5.17. The company has a debt-to-equity ratio of 9.23, a current ratio of 6.56 and a quick ratio of 5.57. The stock has a fifty day moving average price of $1.57 and a 200-day moving average price of $1.86.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Federated Hermes Inc. increased its holdings in shares of Beauty Health by 349,616.0% in the 2nd quarter. Federated Hermes Inc. now owns 370,699 shares of the company's stock valued at $712,000 after acquiring an additional 370,593 shares during the last quarter. Cohen Capital Management Inc. grew its stake in Beauty Health by 344.1% during the 3rd quarter. Cohen Capital Management Inc. now owns 572,848 shares of the company's stock worth $825,000 after buying an additional 443,859 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new position in Beauty Health during the 1st quarter worth approximately $200,000. Russell Investments Group Ltd. purchased a new position in Beauty Health during the 1st quarter worth approximately $279,000. Finally, Caprock Group LLC purchased a new position in Beauty Health during the 2nd quarter worth approximately $38,000. Hedge funds and other institutional investors own 93.26% of the company's stock.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.